Press Releases
The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and sponsored by QuantumLeap Healthcare Collaborative has graduated the first two drugs from its innovative, multidrug standing platform trial.
The National Institutes of Health has selected eight projects to receive support to answer some of the most fundamental problems on traumatic brain injury, including understanding long-term effects of repeated head injuries and improving diagnosis of concussions.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium announced today the launch of a three-year study to track the progression of osteoporosis more precisely and pave the way for more effective treatments. The study, which utilizes data from existing academic and clinical trials, is designed to establish the validity of specific imaging and biochemical markers for bone health.
The Foundation for the National Institutes of Health, in association with the Geoffrey Beene Foundation Alzheimer’s Initiative, today announced Enrico Glaab, Ph.D., research associate at the Luxembourg Centre for Systems Biomedicine, University of Luxembourg, as the grand-prize winner of the first-ever challenge to identify male/female differences in Alzheimer’s Disease (AD). Dr. Glaab will receive $50,000 in awards from the Geoffrey Beene Foundation Alzheimer’s Initiative to continue his research.
The Foundation for the National Institutes of Health, in association with the Geoffrey Beene Foundation Alzheimer’s Initiative, today announced the top four winners of the preliminary round of the first-ever challenge to identify male/female differences in Alzheimer’s Disease (AD).
The Foundation for the National Institutes of Health (FNIH) awarded the first annual Lurie Prize to Ruslan M. Medzhitov, PhD, David W. Wallace Professor of Immunobiology at Yale University School of Medicine and Howard Hughes Medical Institute Investigator, last evening at a ceremony at the Robert H. Lurie Medical Research Center of Northwestern University.
The Foundation for the National Institutes of Health, in association with the Geoffrey Beene Foundation Alzheimer’s Initiative, today announced the first-ever challenge to identify male/female differences in the early cognitive decline that precedes Alzheimer’s disease.
The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has launched a research collaboration to develop new Patient-Reported Outcome measures (PROs) to better evaluate the effectiveness of treatments for common, serious skin infections and community-acquired bacterial pneumonia, or CABP. Developing the new measures is particularly critical given the need for new medicines to treat emerging drug-resistant strains of these infections, which have been on the rise around the world.
The FNIH today announced that the Sports and Health Research Program (SHRP) is seeking NIH grant proposals from experts in the field to study the detection, diagnosis, treatment and prevention of sports-related brain injuries. The SHRP -- sponsored by the NFL in collaboration with the NIH and announced last September — is conducting research focused on the long-term health effect of injuries sustained by professional and amateur athletes in order to gain more insight into serious medical conditions that affect both athletes and the general public.
The Foundation for the National Institutes of Health (FNIH) today announced that Ruslan M. Medzhitov, PhD, David W. Wallace Professor of Immunobiology and Howard Hughes Medical Institute Investigator at Yale University School of Medicine, has been awarded the inaugural Lurie Prize in the Biomedical Sciences for seminal discoveries related to the innate immune system, the human body’s first line of defense against invading organisms which cause infection.